biotech stocks
Covered Call on Call on Corbus Pharmaceuticals (NASDAQ:CRBP) - Potential income return 16.93% in 226 days (27.27% annualized)
On October 19, 2020, we sold 1 covered call on CRBP stock expiring on April 16, 2021. For this trade, we got a $10 premium (before commissions).
CRBP - a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system
This trade comes as the #22 in the month of October, according to our trading plan for this month, the premium generated from this trade makes us about 1.26% from our $600 monthly goal, while in total we have already reached 66.…
Roll Forward Covered Call on Corbus Pharmaceuticals (NASDAQ:CRBP) - Potential income return 28.2% in 232 days (44.27% annualized)
On October 19, 2020, we roll forwarded 1 covered call on CRBP stock with expiry on April 16, 2020. For this trade, we got a small $7.6 premium (after commissions).
This trade was originally established as a credit spread on August 27, we got assinged 100 shares on September 14, 2020 and since then we have been selling covered calls
This trade comes as the #21 in the month of October, according to our trading plan for this month, the premium generated from this trade makes us about 1.26% from…
Roll Forward 2 Covered Calls on Corbus Pharmaceuticals (NASDAQ:CRBP) - Potential income return 20.24% in 127 days (58.08% annualized)
On October 19, 2020, we roll forwarded 2 covered calls on CRBP stock with expiry on January 15, 2020. For this trade, we got a small $11.2 premium (after commissions).
This trade was originally established on September 10, buying 200 shares with CRBP at $2.49 per share, see: Covered Call on CRBP - Potential income return 9.04% in 8 days. Since then we have rolled this trade once: Roll Forward 2 Covered Calls on CRBP - Potential income return 18.15% in 35 days (189.12% annualized)
This trade…
Covered Call on BioCryst Pharmaceuticals (NASDAQ: BCRX) - Potential income return 16.5% in 63 days (95.59% annualized)
On October 16, 2020, we got assigned 400 shares with BCRX stock and sold 4 covered calls on this stock expiring on November 20, 2020. For this trade, we got a $142.40 premium (after commissions)
This trade comes as the #19 in the month of October, according to our trading plan for this month, the premium generated from this trade makes us about 23.73% from our $600 monthly goal, while in total we have already reached 62.45% so far.
BioCryst Pharmaceuticals, Inc. is an American pharmaceutical…
Sold 4 Credit Spreads on BCRX – 7.8% potential return in 28 days (101.63% annualized)
On September 18, 2020, we sold 4 bull put credit spreads on BCRX stock with an expiry set in the next 28 days. For this trade, we got a $144 premium (before commissions)
BioCryst Pharmaceuticals, Inc. is an American pharmaceutical company headquartered in Durham, North Carolina. The company is a late stage biotech company that focuses on oral drugs for rare and serious diseases.
We have been selling naked puts, credit spreads, and covered calls on BCRX stocks with great success since April…
Covered Call on CRBP - Potential income return 63.21% in 50 days
On September 14, 2020, we sold 1 covered call on CRBP stock expiring on October 16, 2020. For this trade, we got a $25 premium (before commissions).
CRBP - a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system
This trade comes as the #16 in the month of September, and if we stick with our trading plan for this month, the premium generated from this trade makes us about 2.9% from our $800 monthly goal, while in total we have…
Closed BCRX Covered Call with +$331 Profit (25.75% yield in 47 days)
On July 17, 2020, our 300 shares of BCRX were called away at the strike price of $5
We started this trade back on June 1, 2020 (Covered Call on BCRX - Potential income return 19.08% in 18 days) and rolled up and double on June 19 (Roll Forward and Double Up 3 Covered Calls on BCRX stock - Potential Income Return 25.75% in 47 days)
This is yet another good example of how covered calls help generate income. We closed this trade with $116 collected in premiums plus we realized a value gain of…